2024-11-14T12:15:06-06:00 2023-12-31 135565207 KPMG LLP 345 PARK AVENUE NEW YORK NY 101540102 990PF 2023-01-01 820656623 THE SILVERSTEIN FOUNDATION FOR PARKINSON'S WITH GBA SILV 9175198108 PO BOX 237137 NEW YORK NY 10023 NATALIE SILVERSTEIN VICE PRES/TREASURER 9175198108 2024-11-13 1 0 DEVIN L DUNCAN P01249521 2127589700 2023 2024-10-15 13:58:12Z X 320724 X 607638 18076 18076 0 625714 18076 0 0 0 0 0 7933 0 0 7933 6031 0 0 6031 200 0 0 0 4991 0 0 4741 19155 0 0 18705 1763500 1763500 1782655 0 0 1782205 -1156941 18076 0 1412230 255290 255290 64078 65434 65434 1476308 320724 320724 18915 18915 18915 18915 X 1457393 301809 1457393 301809 1476308 320724 1457393 -1156941 1357 301809 0 301809 251 0 251 0 251 0 0 500 0 500 0 249 249 0 0 0 0 0 0 0 0 0 0 0 1 1 NY 1 0 0 0 0 1 WWW.SILVERSTEINFOUNDATION.ORG JONATHAN T SILVERSTEIN 9175198108 PO BOX 237137 NEW YORK NY 10023 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 JONATHAN SILVERSTEIN PO BOX 237137 NEW YORK NY 10023 PRESIDENT / CHAIR OF BOARD 40.00 0 0 0 NATALIE SILVERSTEIN PO BOX 237137 NEW YORK NY 10023 VICE PRESIDENT / SECRETARY 20.00 0 0 0 GEOFFREY LEVIN PO BOX 237137 NEW YORK NY 10023 BOARD MEMBER 1.00 0 0 0 NONE 0 NONE 0 0 63624 362331 0 425955 0 0 425955 6389 419566 20978 20978 251 251 20727 0 20727 0 20727 1782205 0 1782205 20727 0 0 0 1782205 0 0 0 20727 1761478 0 0 1761478 0 0 0 0 0 0 0 1761478 1761478 JONATHAN SILVERSTEIN NATALIE SILVERSTEIN THE SILVERSTEIN FOUNDATION FOR PARK PO BOX 237137 NEW YORK NY 10023 9175198108 INFO@SILVERSTEINFOUNDATION.ORG THE FOUNDATION'S BOARD OF TRUSTEES AND SCIENTIFIC ADVISORY COMMITTEE ACCEPT GRANT APPLICATIONS FROM ORGANIZATIONS FOCUSED ON RAPIDLY CONVERTING SCIENTIFIC IDEAS AND EXPERIMENTAL DRUGS INTO FDA APPROVED THERAPEUTICS TO TREAT AND PREVENT THE ONSET OF PARKINSON'S DISEASE IN GBA-MUTATION CARRIERS. THE FOUNDATION REVIEWS QUALIFIED GRANT APPLICATIONS AS RECEIVED. NONE CURASEN THERAPEUTICS 930 BRITTAN AVENUE SUITE 306 SAN CARLOS CA 94070 N/A NC GENOTYPING AND BIOMARKER ANALYSES IN CLINICAL STUDY 225000 THE NEW YORK STEM CELL FOUNDATION 619 WEST 54TH STREET NEW YORK NY 10019 N/A PC DRUG DISCOVERY FOR PARKINSON'S WITH GBA 627500 TEL AVIV SOURASKY MEDICAL CENTER WEIZMANN ST 6 TEL AVIVYAFO IS 6423906 N/A NC THE ROLE OF THE IMMUNE SYSTEM IN GLUOCEREBROSIDASE (GBA)-PD: A CSF AND PBMC STUDY 276000 SUNNYBROOK RESEARCH INSTITUTE 2075 BAYVIEW AVENUE TORONTO ONTARIO CA M4N 3M5 N/A NC A PHASE I/II STUDY FOR BILATERAL PUTAMENAL DELIVERY OF RECOMBINANT GLUCOCEREBROSIDASE IN PATIENTS WITH PARKINSON'S DISEASE USING MR-GUIDED FOCUSED ULTRASOUND INDUCED OPENING OF THE BLOOD-BRAIN BARRIER 250000 HAMAD BIN KHALIFA UNIVERSITY EDUCATION CITY - GATE 8 ARRAYYAN QA 00000 N/A NC THERAPEUTIC NANOBODY DEVELOPMENT FOR TARGETING ALPHA-SYNUCLEIN AGGREGATION IN PARKINSON'S DISEASE, WITH FOCUS ON PARKINSON'S DISEASE WITH GBA MUTATION 190000 THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD WELLINGTON SQUARE OXFORD UK OX1 2JD N/A PC SUPPORT ONE MOVEMENT DISORDERS FELLOW FOR A TWO-YEAR PERIOD WHO HAS A FOCUS ON GBA-PARKINSON'S DISEASE RESEARCH AND/OR CLINICAL DEVELOPMENT 195000 1763500 0 14 18076 0 18076 0 18076 0 0 0 0 0 0 0 0 0 0 X X 1 FIDELITY INVESTMENTS CHARITABLE GIF 245 SUMMER STREET BOSTON MA 02210 600000 X 2 ADAM WOLFSON 358 FIFTH AVENUE 8TH FLOOR NEW YORK NY 10001 5000 X TEL AVIV SOURASKY MEDICAL CENTER WEIZMANN ST 6 TEL AVIVYAFO IS 6423906 2023-02-27 276000 PROJECT: THE ROLE OF THE IMMUNE SYSTEM IN GLUOCEREBROSIDASE (GBA)-PD: A CSF AND PBMC STUDY 31027 NO PENDING 2024-11-05 FUNDS USED IN LINE WITH IRC SECTION 170(C)(2)(B) SUNNYBROOK RESEARCH INSTITUTE 2075 BAYVIEW AVENUE TORONTO ONTARIO CA M4N 3M5 2023-02-22 250000 PROJECT: A PHASE I/II STUDY FOR BILATERAL PUTAMENAL DELIVERY OF RECOMBINANT GLUCOCEREBROSIDASE IN PATIENTS WITH PARKINSONS DISEASE USING MR-GUIDED FOCUSED ULTRASOUND INDUCED OPENING OF THE BLOOD-BRAIN BARRIER 15 NO PENDING 2024-11-05 FUNDS USED IN LINE WITH IRC SECTION 170(C)(2)(B) HAMAD BIN KHALIFA UNIVERSITY EDUCATION CITY - GATE 8 ARRAYYAN QA 00000 2023-08-29 190000 PROJECT: THERAPEUTIC NANOBODY DEVELOPMENT FOR TARGETING ALPHA-SYNUCLEIN AGGREGATION IN PARKINSON'S DISEASE, WITH FOCUS ON PARKINSON'S DISEASE WITH GBA MUTATION 31664 NO 10/1/2023 2024-11-05 FUNDS USED IN LINE WITH IRC SECTION 170(C)(2)(B) CURASEN THERAPEUTICS INC 930 BRITTAN AVENUE SUITE 306 SAN CARLOS CA 94070 2023-01-03 225000 PROJECT: GENOTYPING AND BIOMARKER ANALYSES IN CLINICAL STUDY 25589 NO 2/26/2024 2024-11-05 FUNDS USED IN LINE WITH IRC SECTION 170(C)(2)(B) AUTOMATIC DATA PROCESSING INC COM 16308 16308 ISHARES INC CORE MSCI EMERGING MKTS 36165 36165 GILEAD SCIENCES INC 12961 12961 LEGAL FEES 7933 0 0 7933 SOFTWARE LICENSE AND SUPPORT 2985 0 0 2985 STATE CHARITIES FEE 250 0 0 0 OTHER EXPENSE 1544 0 0 1544 WIRE FEES 212 0 0 212 UNREALIZED (GAIN) / LOSS 1357 OTHER PROFESSIONAL FEES 6031 0 0 6031 TAXES 200 0 0 0